지난 주요뉴스 한국경제TV에서 선정한 지난 주요뉴스 뉴스썸 한국경제TV 웹사이트에서 접속자들이 많이 본 뉴스 한국경제TV 기사만 onoff
-
프로티움사이언스, 안용호 대표이사 신규 선임 2023-04-28 13:07:58
위탁개발(CDO) 및 아키젠 바이오텍 CMC(Chemistry, Manufacturing and Control) 본부를 7년간 이끈 30년 이상의 경험을 보유한 CDMO 전문가이다. 안용호 신임대표는 공정 개발 및 CDMO (위탁공정개발 및 생산) 전문가 답게, '국내 최초'의 수식어가 붙는 업적을 다수 이루었다. 그 예로, 국내 최초 일회용...
- 뉴스 > 산업
- 바로가기
-
FPT 소프트웨어, 베트남·싱가포르·말레이시아 팔란티어 독점 재판매 파트너 선정 2022-10-27 13:19:01
수 있다. 파운드리는 Morgan Stanley(모건 스탠리), Merck KGaA(머크그룹), Airbus(에어버스) 및 Fiat Chrysler Automobiles(피아트 크라이슬러 오토모빌스)와 같은 세계 유수 기업들의 신뢰를 받고 있는 것으로 알려져 있다. FPT 소프트웨어는 FPT만의 전문성과 팔란티어 선두적 플랫폼의 결합을 통해 은행, 금융 서비스,...
- 뉴스 > 산업
- 바로가기
-
[PRNewswire] 새 멤브레인 생산 공장의 상량식을 축하한 Merck 2020-10-09 10:16:02
2019, Merck generated sales of €16.2 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the...
- 뉴스 > 정치·사회·국제
- 바로가기
-
[PRNewswire] Merck Announces Out-Licensing Agreement for Phase II-ready 2020-10-06 21:25:23
to characterize M6495 in future studies with the goal of bringing it to market for osteoarthritis patients. M6495 was originally jointly developed by Merck and Ablynx (now Ablynx, a Sanofi company) as part of a joint discovery and development agreement in 2011; the asset was later solely developed b...
- 뉴스 > 정치·사회·국제
- 바로가기
-
[PRNewswire] Merck Advances Oncology Portfolio and Pipeline with New and 2020-09-14 09:43:33
2019, Merck generated sales of € 16.2 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the...
- 뉴스 > 정치·사회·국제
- 바로가기
-
[PRNewswire] New MAVENCLAD(R) Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting 2020-09-11 21:05:05
2019, Merck generated sales of € 16.2 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the...
- 뉴스 > 정치·사회·국제
- 바로가기
-
[PRNewswire] Merck Announces Positive Phase II Results for Investigational 2020-09-10 21:08:46
both IL-17A and IL-17F with the potential to treat inflammatory diseases, including psoriasis. Currently there are no approved IL-17 A/F nanobodies. Merck acquired full, exclusive rights to the anti-IL-17 A/F Nanobody(R) through a global development and commercialization deal with Ablynx (now Ablyn...
- 뉴스 > 정치·사회·국제
- 바로가기
-
[PRNewswire] 머크, 5천900만 유로 투자로 항체 의약품 포합 물질 제조 시설 확장 2020-09-10 00:43:52
2019, Merck generated sales of €16.2 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the...
- 뉴스 > 정치·사회·국제
- 바로가기
-
[PRNewswire] Merck to Showcase New Data at ACTRIMS-ECTRIMS ... (2/2) 2020-09-04 01:02:52
2019, Merck generated sales of € 16.2 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the...
- 뉴스 > 정치·사회·국제
- 바로가기
-
[PRNewswire] Merck to Showcase New Data at ACTRIMS-ECTRIMS ... (1/2) 2020-09-04 01:02:43
Liverpool Hospital, New South Wales, Australia Today, Merck has launched a newsroom for journalists interested in the company`s latest developments and news - merckneurology.com/newsroom - where, among other information, background information on Merck MS treatments, and video presentations from the...
- 뉴스 > 정치·사회·국제
- 바로가기
